חוב לטווח קצר להון MaxCyte, Inc. (MXCT)

This daily price chart for MaxCyte, Inc. (MXCT) on the GURU.Markets platform illustrates metrics where the value is 0.01. MaxCyte, Inc. (MXCT) dominates the cell modification segment due to its patents and FDA approval. However, export restrictions and political tensions are hindering global sales. The strict integration of equipment with clients' manufacturing protocols makes switching to other platforms virtually impossible due to the risk of losing certification.

MaxCyte, Inc. (MXCT) develops innovative biotechnologies with demand that remains independent of global macroeconomic fluctuations. A stable inflow of capital allows the company to flexibly manage its debt load, which is directly reflected in the share of short-term liabilities within the capital structure. This metric measures the business's reliance on "quick" loans, revealing actual credit pressure and the efficiency of liquidity management. The historical ratio of short-term debt to equity helps distinguish temporary borrowings from sustainable growth.